Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiseptic Mouth Rinses for COVID-19
NCT04584684Phase 2Terminated
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Dec 2020
- Primary completion
- Oct 2021
- Modality
- Conventional Liposomes, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Listerine, cetylpyridinium chloride, hydrogen peroxide, povidone-iodine, chlorhexidine in coronavirus disease 2019 (COVID-19), sponsored by University of North Carolina at Chapel Hill. Started Dec 2020; status: terminated.
02
Drugs
Listerinecetylpyridinium chloridehydrogen peroxidepovidone-iodinechlorhexidine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04584684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04584684.